You can help more patients resume satisfying sexual intercourse with their partners
Boston Scientific accounts are for healthcare professionals only.
Boston Scientific accounts are for healthcare professionals only.
Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.
My Boston Scientific account
Access your online applications and manage your customer profile.
Quick Links
Call customer care
You can help more patients resume satisfying sexual intercourse with their partners
The AMS 700 IPP is the No. 1 market-leading, physician-preferred implant designed for ease of use and to look and feel natural, with over half a million devices sold. You can be confident that the AMS 700 IPP line was designed to address patient needs. In an independent study, 97% of patients would recommend a penile implant to a friend.
Powering the AMS 700™ Inflatable Penile Prosthesis (IPP), the new TENACIO™ Pump is purpose-built from the inside out with advanced engineering and a bold design that aims to streamline the patient experience.
A next-generation device that builds upon the proven legacy of the original Furlow Insertion Tool, the Furlow Disposable Insertion Tool delivers ergonomic features, as-packaged sterility, and off-the-shelf availability.
Designed to closely mimic a natural erection, provide rigidity when inflated and, have a natural, flaccid appearance when deflated, the AMS 700 has a sophisticated cylinder construction layered with silicone and fabric that's designed to maintain a symmetrical shape, regardless of patient anatomy.
The only penile implant on the market with cylinders coated in Parylene, proven in published studies to mitigate cylinder fatigue and increase long-term durability.*
In a survey of 194 patients who received an AMS 700 Penile Implant, 95% were very satisfied or satisfied with their sexual activity. Not a single patient reported dissatisfaction.4
Studies have demonstrated that AMS 700 has resulted in:
56%
reduction (from 2.5% to 1.1%) in revisions due to infection in first-time implant patients1
32%
reduction (from 3.7% to 2.5%) in secondary revision procedures due to infection2
65%
reduction (from 4.17% to 1.47%) in initial revisions due to infection in high-risk patients with diabetes3
In the first episode of this award-winning docuseries, we hear from Cliff about his journey to erectile restoration and his experience with the AMS 700 implant.
“It brought back the old Cliff — the Cliff she married. It brought back the intimacy, and then some, that we had lost.”
— Cliff, AMS 700 Prosthesis patient
*Bench test results may not necessarily be indicative of clinical performance.
References
Disclaimers
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Indications, Safety, and Warnings for the AMS 700
All photographs taken by Boston Scientific. All trademarks are the property of their respective owners.